Bridgeway Capital Management, LLC Acorda Therapeutics Inc Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.52 - $0.77 $13,000 - $19,250	-25,000 Reduced 24.58%	76,706 $59,000
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.67 $42,715 - $237,781	-142,384 Reduced 58.33%	101,706 $47,000
Q4 2021 Feb 14, 2022	BUY	$2.3 - $4.71 $238,049 - $487,485	103,500 Added 73.62%	244,090 $583,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.79 $131,040 - $186,810	39,000 Added 38.39%	140,590 $647,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.23 $112,509 - $162,998	31,166 Added 44.25%	101,590 $485,000
Q1 2021 May 17, 2021	BUY	$3.8 - $8.04 $267,611 - $566,208	70,424 New	70,424 $343,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.